Interstitial lung disease (ILD) is a group of lung conditions that can cause inflammation and scarring in the lungs. As the disease progresses, breathing may become more difficult, and some patients may experience low oxygen levels.

In some people with ILD, another condition called pulmonary hypertension can also develop. This means that the blood pressure in the arteries carrying blood from the heart to the lungs becomes abnormally high.

When pulmonary hypertension develops alongside ILD, it can make breathlessness worse, reduce physical activity and place additional strain on the heart.

Understanding this connection is important because worsening breathlessness in someone with ILD is not always due to increasing lung scarring. Pulmonary hypertension may also be contributing to the problem.

Why Can Pulmonary Hypertension Develop in Patients with ILD?

Interstitial lung disease can affect the normal structure of the lungs and the blood vessels within them.

As lung damage progresses, oxygen levels may fall and the blood vessels in the lungs can become affected. This can make it harder for blood to flow through the lungs.

Over time, the pressure in these blood vessels may increase, leading to pulmonary hypertension.

This type of pulmonary hypertension is generally classified as Group 3, which includes pulmonary hypertension associated with lung diseases and low oxygen levels.

Which Patients with ILD Are at Risk?

Pulmonary hypertension can occur in different types of interstitial lung disease, particularly in patients with more advanced lung damage.

It may be seen in people with:

  • Idiopathic pulmonary fibrosis (IPF).
  • Connective tissue disease-associated ILD.
  • Chronic hypersensitivity pneumonitis.
  • Other forms of progressive pulmonary fibrosis.

However, not everyone with ILD develops pulmonary hypertension. Some patients may have stable lung disease for years without this complication.

What Symptoms Should Patients Watch For?

The symptoms of pulmonary hypertension can overlap with those of interstitial lung disease. This can sometimes make it difficult to recognise when an additional problem has developed.

Patients should pay attention to:

  • Increasing breathlessness, particularly during walking or everyday activities.
  • Becoming tired more easily than before.
  • Difficulty performing activities that were previously manageable.
  • Increasing oxygen requirements.
  • Dizziness or fainting, particularly during physical activity.
  • Swelling of the feet, ankles or legs.

One important warning sign is breathlessness that becomes worse than expected based on the patient’s known lung condition.

For example, someone whose ILD appears relatively stable but who is becoming increasingly breathless may need further assessment for pulmonary hypertension.

How Can Pulmonary Hypertension Affect the Heart?

The right side of the heart pumps blood into the lungs.

When pressure in the pulmonary blood vessels increases, the right side of the heart has to work harder to pump blood.

Over time, this additional strain can cause the right side of the heart to enlarge and weaken.

In advanced cases, patients may develop right-sided heart failure, which can cause leg swelling, fluid retention and worsening breathlessness.

This is why pulmonary hypertension is an important complication to recognise in patients with interstitial lung disease.

How Is Pulmonary Hypertension Identified in Patients with ILD?

Doctors may suspect pulmonary hypertension when a patient with ILD develops worsening breathlessness, declining exercise capacity or increasing oxygen requirements.

An echocardiogram is commonly used to assess the heart and look for signs suggesting pulmonary hypertension.

Other assessments may include pulmonary function tests, a six-minute walk test and chest imaging.

If confirmation is needed, right heart catheterisation can directly measure pressure within the pulmonary circulation.

Not every patient with ILD needs all these investigations. The choice depends on symptoms and the doctor’s assessment.

Can Pulmonary Hypertension Be Treated in Patients with ILD?

Treatment depends on the severity of pulmonary hypertension and the underlying lung condition.

The main aim is to manage the lung disease, maintain adequate oxygen levels and reduce the strain on the heart.

Treatment may include:

Management of ILD: Appropriate treatment of the underlying lung condition is important to help control disease progression.

Oxygen therapy: Patients with low oxygen levels may require supplemental oxygen, depending on their individual needs.

Pulmonary rehabilitation: Supervised exercise and rehabilitation programmes can help patients maintain physical activity and manage breathlessness.

Specific pulmonary hypertension treatment: Selected patients may benefit from medication specifically used for pulmonary hypertension associated with ILD. Inhaled treprostinil is one treatment that may be considered in appropriate patients.

Not all pulmonary hypertension medications are suitable for patients with ILD. Treatment decisions should be made by specialists familiar with both conditions.

Does Every Patient with ILD Develop Pulmonary Hypertension?

No. Pulmonary hypertension does not develop in everyone with interstitial lung disease.

The risk is generally greater in patients with advanced lung disease, significant oxygen deficiency or more extensive damage to the lungs.

However, pulmonary hypertension can sometimes develop even when the underlying lung condition does not appear to have changed significantly.

This is why regular follow-up is important, particularly when patients notice changes in their breathing or physical activity.

When Should Patients Seek Further Assessment?

Patients with ILD should not ignore increasing breathlessness, reduced ability to walk, worsening oxygen levels or new swelling of the legs.

These changes may indicate progression of the underlying lung disease, pulmonary hypertension or another complication.

Early recognition helps doctors identify the reason for worsening symptoms and decide whether additional treatment or specialist assessment is needed.

The Chest Clinic – Dr. Javed Husain & Associates, Karachi

Patients with interstitial lung disease may require regular respiratory assessment to monitor their condition and identify complications such as pulmonary hypertension. At The Chest Clinic, Dr. Javed Husain, Pulmonologist and Critical Care C onsultant, evaluates patients with ILD, pulmonary fibrosis and other chronic respiratory conditions.The clinic provides respiratory assessment, pulmonary function testing and six-minute walk testing, as clinically indicated, to help monitor lung function, exercise capacity and oxygen requirements.

Located in Karachi, The Chest Clinic provides specialist respiratory care and follow-up for patients living with chronic lung diseases.

For appointments and information call +923018479066, +923293364949, or email us at connect@thechestclinic.pk